1. Home
  2. KFRC vs GERN Comparison

KFRC vs GERN Comparison

Compare KFRC & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFRC
  • GERN
  • Stock Information
  • Founded
  • KFRC 1962
  • GERN 1990
  • Country
  • KFRC United States
  • GERN United States
  • Employees
  • KFRC N/A
  • GERN N/A
  • Industry
  • KFRC Professional Services
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KFRC Consumer Discretionary
  • GERN Health Care
  • Exchange
  • KFRC Nasdaq
  • GERN Nasdaq
  • Market Cap
  • KFRC 809.8M
  • GERN 700.6M
  • IPO Year
  • KFRC 1995
  • GERN 1996
  • Fundamental
  • Price
  • KFRC $31.96
  • GERN $1.28
  • Analyst Decision
  • KFRC Buy
  • GERN Buy
  • Analyst Count
  • KFRC 3
  • GERN 8
  • Target Price
  • KFRC $52.33
  • GERN $3.71
  • AVG Volume (30 Days)
  • KFRC 282.5K
  • GERN 10.8M
  • Earning Date
  • KFRC 07-28-2025
  • GERN 08-06-2025
  • Dividend Yield
  • KFRC 4.87%
  • GERN N/A
  • EPS Growth
  • KFRC N/A
  • GERN N/A
  • EPS
  • KFRC 2.39
  • GERN N/A
  • Revenue
  • KFRC $1,361,445,000.00
  • GERN $164,447,000.00
  • Revenue This Year
  • KFRC N/A
  • GERN $159.14
  • Revenue Next Year
  • KFRC $4.06
  • GERN $52.76
  • P/E Ratio
  • KFRC $13.42
  • GERN N/A
  • Revenue Growth
  • KFRC N/A
  • GERN 11877.20
  • 52 Week Low
  • KFRC $31.62
  • GERN $1.09
  • 52 Week High
  • KFRC $67.34
  • GERN $4.84
  • Technical
  • Relative Strength Index (RSI)
  • KFRC 25.49
  • GERN 49.49
  • Support Level
  • KFRC $33.28
  • GERN $1.20
  • Resistance Level
  • KFRC $34.58
  • GERN $1.43
  • Average True Range (ATR)
  • KFRC 1.84
  • GERN 0.08
  • MACD
  • KFRC -1.16
  • GERN 0.02
  • Stochastic Oscillator
  • KFRC 2.15
  • GERN 55.88

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: